Table 1 The HBsAg screening kits used 1999-2009.
From: Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009
Years | Screening kit | Manufacture | Sensitivity | Method |
|---|---|---|---|---|
1999 | Auszyme Monoclonal HBsAg | Quantum II ABBOT | Ad 04 ng/ml, ay 0.7 ng/ml | Manual |
2000 | Auszyme Monoclonal HBsAg | Quantum II ABBOT | Ad 04 ng/ml, ay 0.7 ng/ml | Manual |
2001 | Auszyme Monoclonal HBsAg | Quantum II ABBOT | Ad 04 ng/ml, ay 0.7 ng/ml | Manual |
2002 | Auszyme Monoclonal HBsAg | Quantum II ABBOT | Ad 04 ng/ml, ay 0.7 ng/ml | Manual |
2003 | IMx | ABBOT | Ad 0.22 ng/ml Ay 0.17 ng/ml | Semi automatic |
2004 | IMx | ABBOT | Ad 0.22 ng/ml Ay 0.17 ng/ml | Semi automatic |
2005 | IMx | ABBOT | Ad 0.22 ng/ml Ay 0.17 ng/ml | Semi automatic |
2006 | AxSYM HBsAg (MEIA) | ABBOT | Ad 0.15 ng/mL Ay 0.12 ng/mL ≤0.5 ng/mL | automated |
2007 | AXSYM CMIA | ABBOT | 100% | automated |
2008 | Architect | ABBOT | 100% | fully automate |
2009 | Architect | ABBOT | 100% | fully automate |